EGFR inhibition enhances the antitumor efficacy of a selective BRAF V600E inhibitor in thyroid cancer cell lines.

导出 OA

翻译打印收藏纠错

作者： Yongsheng,Jia ^[1] ; Cuicui,Zhang ^[2] ; Chuanxiang,Hu ^[3] ; Yang,Yu ^[1] ; Xiangqian,Zheng ^[2] ; Yigong,Li ^[1] ; Ming,Gao ^[1]

作者单位： Thyroid and Neck Department, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China. ^[1] Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China. ^[2] Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China. ^[3]

关键词 BRAF V600E endothelial growth factor receptor inhibition resistance mitogen assisted protein kinase selective inhibitor

DOI 10.3892/ol.2018.8093

PMID 29616135

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交